المؤلفون: Gregory P. Arutyunov, Yuri M. Lopatin, Aleksandr S. Ametov, Fail T. Ageev, Mikhail B. Antsiferov, Svetlana V. Villevalde, Nadezhda G. Vinogradova, Gagik R. Galstyan, Albert S. Galyavich, Sergey R. Gilyarevskiy, Maria G. Glezer, Igor V. Zhirov, Mikhail V. Ilyin, Anastasiya Iu. Lebedeva, Sergey M. Nedogoda, Vladimir V. Salukhov, Ekaterina I. Tarlovskaya, Sergey N. Tereshchenko, Igor V. Fomin, Iurii Sh. Khalimov, Niaz R. Khasanov, Dmitriy V. Cherkashin, Sergey S. Yakushin

المصدر: Терапевтический архив, Vol 93, Iss 12, Pp 1491-1497 (2021)

مصطلحات موضوعية: empagliflozin, chronic heart failure, hospitalization, decompensation of chronic heart failure, cardiovascular mortality, chronic kidney disease, emperor-preserved trial, emperor-reduced trial, empa-reg outcome trial, clinical inertia, Medicine

وصف الملف: electronic resource

Relation: https://ter-arkhiv.ru/0040-3660/article/viewFile/96474/70727; https://doaj.org/toc/0040-3660; https://doaj.org/toc/2309-5342

URL الوصول: https://doaj.org/article/cb0d25caa8e542fa8a22693834a280ca

المؤلفون: Serguei V. Nedogoda, Yuri M. Lopatin, Vladimir I. Petrov, Alexei V. Sobanov

المصدر: American Journal of Hypertension. 14:A113

مصطلحات موضوعية: Blood pressure, Pharmacotherapy, business.industry, medicine.drug_class, Pharmacological management, Internal Medicine, Medicine, Middle-aged adult, Pharmacoepidemiology, Pharmacology, business, Beta blocker, Persistence (computer science)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5aeb46d172c8160a00a705ad0689eb60
https://doi.org/10.1016/s0895-7061(01)01441-8